235 related articles for article (PubMed ID: 12820463)
21. Potential advantages of loco-regional intra-arterial chemotherapy.
Cagol PP; Pasqual E; Bacchetti S
In Vivo; 2006; 20(6A):777-9. PubMed ID: 17203767
[TBL] [Abstract][Full Text] [Related]
22. Synergistic antitumor effects of histamine plus melphalan in isolated hepatic perfusion for liver metastases.
Brunstein F; Eggermont AM; de Wiel-Ambagtsheer Ga; van Tiel ST; Rens J; ten Hagen TL
Ann Surg Oncol; 2007 Feb; 14(2):795-801. PubMed ID: 17096052
[TBL] [Abstract][Full Text] [Related]
23. Early destruction of tumor vasculature in tumor necrosis factor-alpha-based isolated limb perfusion is responsible for tumor response.
Hoving S; Seynhaeve AL; van Tiel ST; aan de Wiel-Ambagtsheer G; de Bruijn EA; Eggermont AM; ten Hagen TL
Anticancer Drugs; 2006 Sep; 17(8):949-59. PubMed ID: 16940805
[TBL] [Abstract][Full Text] [Related]
24. Isolated hepatic perfusion for the treatment of patients with advanced liver metastases from pancreatic and gastrointestinal neuroendocrine neoplasms.
Grover AC; Libutti SK; Pingpank JF; Helsabeck C; Beresnev T; Alexander HR
Surgery; 2004 Dec; 136(6):1176-82. PubMed ID: 15657573
[TBL] [Abstract][Full Text] [Related]
25. [New models of experimental chemotherapy of tumors].
Treshchalina EM; Andronova NV; Kobliakov VA; Raĭkhlin NT
Vopr Onkol; 2001; 47(6):701-5. PubMed ID: 11826492
[TBL] [Abstract][Full Text] [Related]
26. Locoregional treatment of malignant hepatic tumors with biologic response modifiers.
Yamamoto A; Sato T
Surg Oncol Clin N Am; 2008 Oct; 17(4):935-55, xii. PubMed ID: 18722927
[TBL] [Abstract][Full Text] [Related]
27. Isolated hepatic perfusion for the treatment of liver metastases.
Boone BA; Bartlett DL; Zureikat AH
Curr Probl Cancer; 2012; 36(2):27-76. PubMed ID: 22464447
[No Abstract] [Full Text] [Related]
28. Augmentation of the effect of doxorubicin with low-dose tumor necrosis factor in experimental liver metastasis.
Bloom ND; Norbergs DA; Sherman B; Sadjadi M; Ramaswamy G; Jacobs R; Ackerman N
Mol Biother; 1990 Jun; 2(2):121-4. PubMed ID: 2363856
[TBL] [Abstract][Full Text] [Related]
29. Current status of isolated hepatic perfusion with or without tumor necrosis factor for the treatment of unresectable cancers confined to liver.
Alexander HR; Bartlett DL; Libutti SK
Oncologist; 2000; 5(5):416-24. PubMed ID: 11040278
[TBL] [Abstract][Full Text] [Related]
30. Tumor vascular therapy with TNF: critical review on animal models.
Hagen TL; Eggermont AM
Methods Mol Med; 2004; 98():227-46. PubMed ID: 15064444
[TBL] [Abstract][Full Text] [Related]
31. Isolated limb perfusion for melanoma.
Kroon BB; Noorda EM; Vrouenraets BC; van Slooten GW; Nieweg OE
Surg Oncol Clin N Am; 2008 Oct; 17(4):785-94, viii-ix. PubMed ID: 18722918
[TBL] [Abstract][Full Text] [Related]
32. Isolated hepatic perfusion: a regional therapy for liver cancer.
Yang ZW; Xu GL
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):12-6. PubMed ID: 14969830
[TBL] [Abstract][Full Text] [Related]
33. [Hepatic cancer].
Kako M
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):307-10. PubMed ID: 2649003
[TBL] [Abstract][Full Text] [Related]
34. Changing the pathophysiology of solid tumours: the potential of TNF and other vasoactive agents.
ten Hagen TL; Eggermont AM
Int J Hyperthermia; 2006 May; 22(3):241-6. PubMed ID: 16754345
[TBL] [Abstract][Full Text] [Related]
35. [Selective hepatic perfusion of anti-neoplastic drugs chmotherapy of liver cancer combined with surgery].
Shiraha Y
Gan No Rinsho; 1967 Dec; 13(12):1087. PubMed ID: 5628102
[No Abstract] [Full Text] [Related]
36. Is there any reason to delay introduction of tumor necrosis factor in the management of in-transit metastasis of unresectable melanoma?
Garrido-Laguna I; Ponz M; Espinós J
J Clin Oncol; 2007 Mar; 25(9):1149; author reply 1149-51. PubMed ID: 17369585
[No Abstract] [Full Text] [Related]
37. Synergistic antitumor activity of histamine plus melphalan in isolated limb perfusion: preclinical studies.
Brunstein F; Hoving S; Seynhaeve AL; van Tiel ST; Guetens G; de Bruijn EA; Eggermont AM; ten Hagen TL
J Natl Cancer Inst; 2004 Nov; 96(21):1603-10. PubMed ID: 15523089
[TBL] [Abstract][Full Text] [Related]
38. [Intrahepatic arterial microcirculation. Clinical findings. Anatomical study. Physiopathological data. Therapeutic deductions].
Isman H
J Chir (Paris); 1974 Feb; 107(2):105-16. PubMed ID: 4426941
[No Abstract] [Full Text] [Related]
39. Current clinical and research approaches to optimizing regional chemotherapy: novel strategies generated through a better understanding of drug pharmacokinetics, drug resistance, and the development of clinically relevant animal models.
Beasley GM; Kahn L; Tyler DS
Surg Oncol Clin N Am; 2008 Oct; 17(4):731-58, vii-viii. PubMed ID: 18722915
[TBL] [Abstract][Full Text] [Related]
40. The role of aggressive regional therapy for colorectal liver metastases.
White RR; Jarnagin WR
Cancer Invest; 2007 Sep; 25(6):458-63. PubMed ID: 17882658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
